Latest News & Features
Americas
Years-long dispute centred on treatment for gastroesophageal reflux disease | Case invited questions concerning Noerr-Pennington doctrine and immunity | Takeda | Zydus. 13 December 2022
Americas
Two rivals withdrew from acquisition process| Agreement provides access to blockbuster medicines | Janssen Global Services | Sanofi. 13 December 2022
article
Firm promotes life sciences lead | New managing partner will play a role in international IP services group. 8 December 2022
Big Pharma
Big pharma firm accused of copying technology when developing vaccine | Dispute will also play out in Germany | BioNTech | Moderna. 8 December 2022
Americas
Extension is “pathetic” says vaccine charity coalition | US Trade Representative says extra time will “help the world make a more informed decision” about
the controversial patent waiver. 8 December 2022
Big Pharma
New addition comes from Fieldfisher | Practice will extend across the US, UK and Continental Europe | renewables and cleantech. 6 December 2022
Big Pharma
Agency found to have breached deal regarding research | Pharma firm accused of piggybacking on public research| Centers for Disease Control and Prevention. 6 December 2022
Big Pharma
Medicines Patent Pool deals have given 20 million people access to HIV treatment | Full list of sub-licensees. 6 December 2022
Americas
Ex-partners collaborated on a clinical study for a cancer treatment | Pharma firm insists that it has exclusive licensing rights | MSD | John Hopkins. 1 December 2022
Big Pharma
As the ‘UK+’ exhaustion regime is set to continue for now, Rebecca Anderson-Smith of Mewburn Ellis explores how pharma firms should protect their rights. 1 December 2022